[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fhuad4xfzv4vqQyiRYG1x9_kqqxMmAPFbpMnAQ0jIu5U":8,"$f_ytz5voN5Nv4cP72g6OcFEqMFkM_caD7EnKguFBnlEs":55,"$f4CoYgh5u41LSoIeVrTvHCAMWf7pYSeC5XEYcZ1Kiyvo":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},75847,867263,[],"https://ystcdn.venuertc.com/medical/ystApp/0YbWrtsGnIVSTzEaDbtlD7CaJRSwuqG9.png","李会敏","临清市人民医院","老年病内科","住院医师",384,0,"肺腺癌四期用药安全手册：老年患者实用细节全解 💊🧓","","https://ystcdn.venuertc.com/venue/AI/ef331fb3-c972-490e-97b3-16e5da559abf.jpg","\u003Ch2 id=\"material_title\" class=\"lung-drug-title\">肺腺癌四期用药安全手册：老年患者实用细节全解 \u003Cspan style=\"font-size:1.2em;\">💊🧓\u003C/span>\u003C/h2>\n\n\u003Cdiv class=\"lung-drug-section lung-drug-section-bg\">\n  \u003Ch3 class=\"lung-drug-subtitle\">引言：药物治疗，细节最关键\u003C/h3>\n  \u003Cdiv class=\"lung-drug-content\">\n    平时说起“靶向药”或“化疗药”，很多人会觉得一头雾水。其实这些药物的用途很明确：帮助病友更好地完成难治阶段的用药计划。无论是吉非替尼、培美曲塞、贝伐珠单抗还是最新的阿美替尼、伏美替尼，每种药物有独特的使用讲究。本文将用7个要点带你彻底梳理老年患者使用这类药物的正确方法、各项注意事项和安全原则，让家庭照护更安心。\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"lung-drug-section lung-drug-section-bg\">\n  \u003Ch3 class=\"lung-drug-subtitle\">01 服药时间与方法：要点不容忽视 ⏰\u003C/h3>\n  \u003Cdiv class=\"lung-drug-content\">\n    \u003Cul>\n      \u003Cli>\n        \u003Cb>吉非替尼、阿美替尼、伏美替尼（口服靶向药）：\u003C/b>一般建议每日一次，尽量固定时间。建议空腹或餐后2小时服用。部分药物推荐用温水整片吞服，不要咬碎、掰开或研粉。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>培美曲塞、多西他赛、吉西他滨（静脉化疗药）：\u003C/b>都需在医院由专业人员静脉滴注，不可自行在家操作。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>贝伐珠单抗（静脉输注）：\u003C/b>每2-3周一次，过程需严密监测血压与过敏反应。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>正确做法：\u003C/b>未明确说明餐前/餐后时，请严格参照药品说明书或药师建议执行。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cspan class=\"lung-drug-note\">⚠️ 服用漏服时，不要自行补服双倍剂量，应继续下一次正常剂量。\u003C/span>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"lung-drug-section lung-drug-section-bg\">\n  \u003Ch3 class=\"lung-drug-subtitle\">02 剂型特点和服用技巧 📦\u003C/h3>\n  \u003Cdiv class=\"lung-drug-content\">\n    \u003Cul>\n      \u003Cli>\n        \u003Cb>吉非替尼、阿美替尼、伏美替尼：\u003C/b>均为薄膜衣片或胶囊，仅限口服。对于吞咽有困难的老年人，部分药品允许将药片溶解于少量水（具体遵照说明书），但并非所有靶向药都支持此操作。务必确认药品说明。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>培美曲塞、吉西他滨、多西他赛、贝伐珠单抗：\u003C/b>均为注射剂型，要求医院专业环境，家庭无法自行进行。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>正确做法：\u003C/b>服药前检查药品外观，无破损、变色或异味。如发现异常，请勿服用，及时告知医护人员。\n      \u003C/li>\n    \u003C/ul>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"lung-drug-section lung-drug-section-bg-alt\">\n  \u003Ch3 class=\"lung-drug-subtitle\">03 药物作用机制简述 🔬\u003C/h3>\n  \u003Cdiv class=\"lung-drug-content\">\n    \u003Cul>\n      \u003Cli>\n        \u003Cb>吉非替尼、阿美替尼、伏美替尼：\u003C/b>本类药属于EGFR-TKI，简单理解为通过抑制某些异常活跃的受体蛋白活性，阻挡异常细胞的生长信号，从而控制异常细胞的繁殖（Lindeman et al., 2013）。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>培美曲塞、吉西他滨、多西他赛：\u003C/b>多属细胞毒性药物或反代谢药，通过破坏异常细胞的DNA合成与分裂来起作用（Scagliotti et al., 2008）。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>贝伐珠单抗：\u003C/b>是一种抗血管生成药，能阻断异常细胞周围的血管生成，减少给异常细胞的营养供应（Ferrara et al., 2004）。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cspan class=\"lung-drug-note\">这些机制是药物发挥作用的基础，但与用法用量分开，不影响具体服药操作！\u003C/span>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"lung-drug-section lung-drug-section-bg-alt\">\n  \u003Ch3 class=\"lung-drug-subtitle\">04 特殊人群用药调整 🎯\u003C/h3>\n  \u003Cdiv class=\"lung-drug-content\">\n    \u003Cul>\n      \u003Cli>\n        \u003Cb>老年患者：\u003C/b>部分药物（如吉西他滨、多西他赛）对肝肾功能不全或体质虚弱者，需减量或调整给药频率。实际使用由医师综合判断，不宜自行调整。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>合并高血压、心血管问题：\u003C/b>使用贝伐珠单抗时需谨慎，治疗期间需定期监测血压、心功能表现。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>服药经验举例：\u003C/b>有位老年患者在使用伏美替尼联合多西他赛后，因为医生按说明书减量调整，安全度过了用药适应期。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>正确做法：\u003C/b>所有剂量改变只可由医师根据评估结果下达，不可自行增减药量。\n      \u003C/li>\n    \u003C/ul>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"lung-drug-section lung-drug-section-bg\">\n  \u003Ch3 class=\"lung-drug-subtitle\">05 常见不良反应与应对办法 ⚠️\u003C/h3>\n  \u003Cdiv class=\"lung-drug-content\">\n    \u003Cul>\n      \u003Cli>\n        \u003Cb>吉非替尼、阿美替尼、伏美替尼：\u003C/b>常见不良反应包括皮疹、胃肠反应等。皮疹多为轻度，发现时可告知医生，严重时可能需调整用药方案。说明书显示，皮疹发生率可达40%-50%（Mok et al., 2009）。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>培美曲塞、吉西他滨、多西他赛：\u003C/b>部分患者可出现消化道反应、白细胞减少等，不同药物反应发生率及处理方式各异。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>贝伐珠单抗：\u003C/b>可能导致高血压、蛋白尿、出血等。报告副作用时，需及时就医评估。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>出现不良反应时：\u003C/b>轻度反应可记录并随访，严重反应（如持续高热、异常出血、严重皮疹等）须立即就医，不得延误。\n      \u003C/li>\n    \u003C/ul>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"lung-drug-section lung-drug-section-bg-alt\">\n  \u003Ch3 class=\"lung-drug-subtitle\">06 药物相互作用要点 🧩\u003C/h3>\n  \u003Cdiv class=\"lung-drug-content\">\n    \u003Cul>\n      \u003Cli>\n        \u003Cb>吉非替尼、伏美替尼、阿美替尼：\u003C/b>与抗酸药、质子泵抑制剂等会影响吸收。服用前后应间隔至少6小时。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>多西他赛、吉西他滨：\u003C/b>能与其他抑制肝脏代谢酶的药物发生相互作用，增加毒性风险。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>贝伐珠单抗：\u003C/b>若同时使用其它抑制血小板功能药物（如阿司匹林）需特别注意出血风险。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>正确做法：\u003C/b>如需联合多种药物，应提前向药师详细咨询，了解所有药物间的间隔或禁忌。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>案例补充：\u003C/b>临床有患者因未注意与养胃药同服，影响了吉非替尼血药浓度，后经指导分开服用后效果改善。\n      \u003C/li>\n    \u003C/ul>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"lung-drug-section lung-drug-section-bg\">\n  \u003Ch3 class=\"lung-drug-subtitle\">07 药品储存与有效期 🗃️\u003C/h3>\n  \u003Cdiv class=\"lung-drug-content\">\n    \u003Cul>\n      \u003Cli>\n        \u003Cb>存储温度：\u003C/b>绝大多数口服靶向药、化疗药片需存放于25℃以下干燥阴凉处。部分注射剂型需冷藏（2~8℃），具体见药品说明书。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>开封后保存：\u003C/b>部分药片拆开包装后7天内需用完，注射用药需即配即用，剩余药液严禁自行保存。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>过期药物处理：\u003C/b>过期或用剩药品应送到正规回收点或医院回收柜处理，切勿自行丢弃或随意转让。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>正确做法：\u003C/b>药品应保存于儿童无法触及的地方，防潮防晒防高温。\n      \u003C/li>\n    \u003C/ul>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"lung-drug-section lung-drug-section-bg-alt\">\n  \u003Ch3 class=\"lung-drug-subtitle\">08 漏服和过量处理指南 📝\u003C/h3>\n  \u003Cdiv class=\"lung-drug-content\">\n    \u003Cul>\n      \u003Cli>\n        \u003Cb>漏服：\u003C/b>如发现漏服，第一时间补服需谨慎。一般情况下，若接近下一次服药时间，可直接跳过，不要加倍补服。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>过量：\u003C/b>如不慎服药过量，应立即联系医生或最近的急诊服务中心，切勿自行处理。部分靶向药过量会带来严重并发症。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cspan class=\"lung-drug-note\">安全服药，切忌擅自操作！\u003C/span>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"lung-drug-section lung-drug-section-bg\">\n  \u003Ch3 class=\"lung-drug-subtitle\">09 家庭照护与日常配合 🤝\u003C/h3>\n  \u003Cdiv class=\"lung-drug-content\">\n    \u003Cul>\n      \u003Cli>\n        \u003Cb>药品管理：\u003C/b>建议设定固定服药日历与提醒，协助老人规范携带与使用药物。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>生活习惯：\u003C/b>配合均衡饮食，维持良好作息，避免自行加停或调整药物。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>就医复诊：\u003C/b>按医嘱定期回医院复诊，及时监测可能出现的化验指标波动。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>沟通交流：\u003C/b>家人和患者应主动与医生、药师保持良好沟通，记录任何异常情况。\n      \u003C/li>\n    \u003C/ul>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"lung-drug-section lung-drug-section-bg-alt\">\n  \u003Ch3 class=\"lung-drug-subtitle\">10 结语：安全用药，从每一个细节做起 ✨\u003C/h3>\n  \u003Cdiv class=\"lung-drug-content\">\n     综合来看，靶向治疗药物、化疗药物、抗血管生成药在实际使用中有许多独立且关键的用药细节。每一步按规范执行，都能为老年患者的治疗安全加分。最需要关注的，一是不能随意增减剂量或漏服补服，二是要严格避免不必要的药物相互作用。配合科学管理和积极沟通，大家都能更安心地度过每一个用药周期。遇到疑问或异常，记得及时咨询医生或药师，切莫自行判断。\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"lung-drug-section lung-drug-section-bg\">\n  \u003Ch3 class=\"lung-drug-subtitle\">核心用药细节小结 \u003Cspan style=\"font-size:1.2em;\">📚\u003C/span>\u003C/h3>\n  \u003Cdiv class=\"lung-drug-content\">\n    \u003Col>\n      \u003Cli>所有靶向、化疗、抗血管生成药物务必严格按时、按量、按方式使用；\u003C/li>\n      \u003Cli>误服、漏服、过量等特殊情况禁止自行处理，需要第一时间求助专业人士；\u003C/li>\n      \u003Cli>出现不良反应或新情况，切忌拖延，需立刻如实向医生反映。\u003C/li>\n    \u003C/ol>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"lung-drug-section lung-drug-section-bg-alt\">\n  \u003Ch3 class=\"lung-drug-subtitle\">参考文献 \u003Cspan style=\"font-size:1.1em;\">🔖\u003C/span>\u003C/h3>\n  \u003Cdiv class=\"lung-drug-content lung-drug-references\">\n    \u003Col>\n      \u003Cli>Lindeman, N. I., Cagle, P. T., Beasley, M. B., et al. (2013). Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology. \u003Ci>Archives of Pathology & Laboratory Medicine\u003C/i>, 137(6), 828-860.\u003C/li>\n      \u003Cli>Scagliotti, G.V., Parikh, P., von Pawel, J., et al. (2008). Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non–small-cell lung cancer. \u003Ci>Journal of Clinical Oncology\u003C/i>, 26(21), 3543-3551.\u003C/li>\n      \u003Cli>Ferrara, N., Hillan, K. J., Gerber, H. P., & Novotny, W. (2004). Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer. \u003Ci>Nature Reviews Drug Discovery\u003C/i>, 3(5), 391-400.\u003C/li>\n      \u003Cli>Mok, T. S., Wu, Y. L., Thongprasert, S., et al. (2009). Gefitinib or carboplatin–paclitaxel in pulmonary adenocarcinoma. \u003Ci>The New England Journal of Medicine\u003C/i>, 361(10), 947-957.\u003C/li>\n    \u003C/ol>\n  \u003C/div>\n\u003C/div>\n\n\u003Cstyle>\n.lung-drug-title {\n  margin: 30px 0 20px 0;\n  font-size: 2em;\n  color: #243C5A;\n  letter-spacing: 1px;\n  text-align: center;\n}\n\n.lung-drug-section {\n  margin: 28px 0 32px 0;\n  border-radius: 10px;\n  padding: 0 0 18px 0;\n  box-sizing: border-box;\n}\n\n.lung-drug-section-bg {\n  background: linear-gradient(90deg, #f2f7fb 0%, #f8fafc 100%);\n  box-shadow: 0 2px 8px rgba(36,60,90,0.08);\n}\n\n.lung-drug-section-bg-alt {\n  background: linear-gradient(90deg, #f9fafc 0%, #f4f7fa 100%);\n  box-shadow: 0 2px 8px rgba(36,60,90,0.05);\n}\n\n.lung-drug-subtitle {\n  margin: 0 0 14px 0;\n  font-size: 1.34em;\n  color: #33688D;\n  font-weight: bold;\n  letter-spacing: .5px;\n  padding: 19px 0 8px 30px;\n  background-image: linear-gradient(90deg, #d8e9fa 0%, #f0f6fa 100%);\n  border-top-left-radius: 10px;\n  border-top-right-radius: 10px;\n}\n\n.lung-drug-content {\n  padding: 0 28px 8px 28px;\n  font-size: 1.10em;\n  color: #222831;\n  line-height: 1.96em;\n  letter-spacing: 0.06em;\n}\n\n.lung-drug-content ul, .lung-drug-content ol {\n  margin: 12px 0 0 25px;\n  padding: 0 0 0 0;\n  font-size: 1em;\n}\n\n.lung-drug-content li {\n  margin: 9px 0 11px 0;\n  padding: 0;\n}\n\n.lung-drug-note {\n  display: block;\n  margin: 14px 0 0 0;\n  color: #B96837;\n  background: linear-gradient(90deg, #f9ebd4 0%, #fffaf4 100%);\n  border-left: 4px solid #E7B279;\n  padding: 9px 16px;\n  border-radius: 4px;\n  font-size: 1em;\n}\n\n.lung-drug-references ol {\n  margin: 7px 0 3px 23px;\n  font-size: 0.96em;\n}\n\n.lung-drug-references li {\n  margin: 4px 0 6px 0;\n  line-height: 1.6em;\n}\n\n@media (max-width: 700px) {\n  .lung-drug-title {\n    font-size: 1.3em;\n    padding: 0 8px;\n  }\n  .lung-drug-section {\n    padding: 0 0 12px 0;\n  }\n  .lung-drug-content { padding: 0 13px 8px 13px; font-size: 1em;}\n  .lung-drug-subtitle { font-size: 1.08em; padding-left: 12px;}\n}\n\n\u003C/style>","\u003Ch2 id=\"material_title\" class=\"lung-drug-title\">肺腺癌四期用药安全手册：老年患者实用细节全解 \u003Cspan style=\"font-size:1.2em;",525,"2025-12-09 00:39:32","肺腺癌, 老年患者, 用药安全, 靶向药, 化疗药","本文深入解析肺腺癌四期老年患者用药的注意细节，提供靶向药及化疗药的安全使用方法，帮助患者顺利度过治疗期。","2025-12-15 14:37:03",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]